PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Data have shown that Metabolic Syndrome, rather than the gene polymorphisms studied (PNPLA3 rs738409, TM6SF2 rs58542926 and MBOAT7 rs641738), predicted an increased mortality owing to either overall causes or cardiovascular diseases among NAFLD subjects [88].